EMEA news briefs

Published: 6-Dec-2006

The European Medicines Agency (EMEA) has issued guidance on how admission of Bulgaria and Romania to the European Union (EU) on 1 January 2007 will affect market approval applications for orphan drugs. www.emea.eu.int/pdfs/human/comp/42226406en.pdf


The European Medicines Agency (EMEA) has issued guidance on how admission of Bulgaria and Romania to the European Union (EU) on 1 January 2007 will affect market approval applications for orphan drugs. www.emea.eu.int/pdfs/human/comp/42226406en.pdf

Meanwhile, EMEA has released new guidance on its market approval procedures for generic/hybrid medicine applications www.emea.eu.int/pdfs/human/euleg/22541106en.pdf

It has also issued a list of patients' and consumers' organisations officially able to participate in the agency's activities www.emea.eu.int/pdfs/human/patientgroup/41635606en.pdf

You may also like